Is Insulet Corp. (PODD) a Buy, Sell, or Hold?
NASDAQ : PODD
Insulet Corp.
$163.72 USD
-$3.65 (-2.18%)
- Volume
- 1.14M
- Average Volume
- 1.59M
- Market Capitalization
- $11.34B
- P/E Ratio
- 37.99
- Dividend Yield
- 0.00%
- Price Target
- $213.00
- Year High
- $354.88
- Year Low
- $138.79
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.49
Company Overview
NASDAQ
Ashley McEvoy
Medical - Devices
Healthcare
PODD
5400
US
USD
Liquidity Metrics
0.73
2.49
1.81
0.70
0.00
Sales & Valuation
$2.71B
3.91
8.80
27.51
5.89
Profitability
$3.48
$247.1M
10.44%
13.94%
21.38%
10.14%
P/E Metrics
37.99
-1.52
-1.52
Analyst Price Target & Rating
$213.00
$249.00
$180.00
3/5
50 Analysts
-23.14%
Financial Health Scores
6.13
7/9
$1.02B
$2.99B
$1.68B
$473.9M
Key Metrics (TTM)
$12.06B
4.16
20.97
2.49
21.38%
16.39%
2.59%
3.56%
$42.57
204 days
Company Executives
| Name | Title |
|---|---|
| Amit Guliani | Senior Vice President & Chief Technology Officer |
| Chuck Medovich | Senior VP and Chief Quality, Regulatory & Compliance Officer |
| Ashley A. McEvoy | Chief Executive Officer, President & Director |
| John Wodick Kapples | Senior Vice President & General Counsel |
| Philip Hildale | Senior Vice President of Sales & Customer Care |
| Angela Geryak Wiczek | Senior Director of Corporate Communications |
| Clare Trachtman | Vice President of Investor Relations |
| Prem Singh | Senior Vice President of Global Operations |
| Eric Benjamin | Executive Vice President & Chief Operating Officer |
| Flavia H. Pease | Executive Vice President & Chief Financial Officer |
Poll Results
No votes yet today — be the first to share your view!
About Insulet Corp. (NASDAQ:PODD) Stock
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the ri ... sk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
2026-07-21 12:16:00
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) and certain officers. The class action, filed in the United States District Court for the District of Massachusetts, and docketed under 26-cv-13062, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Insulet securities between February 21, 2025 and May 26, 2026, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
2026-07-21 10:24:00
LOS ANGELES, July 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Insulet Corporation (“Insulet” or “the Company”) (NASDAQ: PODD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 21, 2025 and May 26, 2026, inclusive (the “Class Period”), are encouraged to contact the firm before August 31, 2026.
2026-07-21 10:07:00
NEW YORK, July 21, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Insulet Corporation (NASDAQ: PODD). Shareholders who purchased shares of PODD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
2026-07-21 09:59:00
Confidence in Insulet's Manufacturing Story Collapsed After Two Omnipod Recalls Exposed Quality Failures Resulting in Analysts Questioning the Scope of Insulet's Manufacturing and Quality-Control Issues Confidence in Insulet's Manufacturing Story Collapsed After Two Omnipod Recalls Exposed Quality Failures Resulting in Analysts Questioning the Scope of Insulet's Manufacturing and Quality-Control Issues
2026-07-21 07:33:00
SAN DIEGO, July 21, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Insulet Corporation (NASDAQ: PODD) securities between February 21, 2025 and May 26, 2026. Insulet develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the U.S. and internationally.
PODD Lawsuit Notice: Insulet Safety Issues and 6% Stock Drop Trigger Securities Fraud Class Action
2026-07-21 06:17:00
A securities fraud class action lawsuit has been filed on behalf of Insulet investors after its stock plummeted over 6% because of misrepresentation about the safety of Insulet's Omnipod products. NEW YORK, July 21, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Insulet Corporation (NASDAQ:PODD) and certain of the Company's senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws.
2026-07-20 14:54:00
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Insulet Corporation (NASDAQ: PODD) between February 21, 2025 and May 26, 2026, inclusive (the “Class Period”), of the important August 31, 2026 lead plaintiff deadline.
2026-07-20 14:42:00
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Insulet To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Insulet between February 21, 2025 and May 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - July 20, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Insulet Corporation ("Insulet" or the "Company") (NASDAQ: PODD) and reminds investors of the August 31, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Frequently Asked Questions
-
What is the current Insulet Corp. (PODD) stock price?
-
Insulet Corp.(NASDAQ:PODD) stock price is $163.72 in the last trading session. During the trading session, PODD stock reached the peak price of $354.88 while $138.79 was the lowest point it dropped to. The percentage change in PODD stock occurred in the recent session was --2.18% while the dollar amount for the price change in PODD stock was -$3.65.
-
PODD's industry and sector of operation?
-
The NASDAQ listed PODD is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of PODD?
-
Amit Guliani | Senior Vice President & Chief Technology Officer
Chuck Medovich | Senior VP and Chief Quality, Regulatory & Compliance Officer
Ashley A. McEvoy | Chief Executive Officer, President & Director
John Wodick Kapples | Senior Vice President & General Counsel
Philip Hildale | Senior Vice President of Sales & Customer Care -
How many employees does PODD have?
-
Number of PODD employees currently stands at 5400. PODD operates from 100 Nagog Park, Acton, MA 01720, US.
-
Link for PODD official website?
-
Official Website of PODD is: https://www.insulet.com
-
How do I contact PODD?
-
PODD could be contacted at phone #978 600 7000 and can also be accessed through its website. PODD operates from 100 Nagog Park, Acton, MA 01720, US.
-
How many shares of PODD are traded daily?
-
The average number of PODD shares traded daily for last 3 months was 1.59M.
-
What is the market cap of PODD currently?
-
The market value of PODD currently stands at $11.34B with its latest stock price at $163.72